RxDoctor Payments DataLook up a doctor →

Ehtisham Mahmud, MD

Interventional Cardiology · San Diego, CANPI 1730112335

Payments from drug & device makers

$1,491,357in general payments, 2019–2025

Across 243 payments — averaging $6137.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$479K
  • Vektor Medical Inc.$250K
  • Cardiovascular Systems Inc.$213K
  • Cathworks, Inc.$154K
  • Abbott$120K
  • Corindus Inc.$87K
  • plus $188K from 12 others
$150in research payments, 2019–2025

Across 2 payments — averaging $75.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abiomed$150

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,491,357 in reported general payments places this provider in the 95th percentile of 585 interventional cardiology providers in California.

See all interventional cardiology providers in California

Medicare billing

Part B allowed, 2024
$153,397
Medicare patients
196
Services billed
775

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →